↓ Skip to main content

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

Overview of attention for article published in Molecular Cancer, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
2 patents

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
Published in
Molecular Cancer, August 2014
DOI 10.1186/1476-4598-13-194
Pubmed ID
Authors

Deborah JL Wong, Lidia Robert, Mohammad S Atefi, Amanda Lassen, Geetha Avarappatt, Michael Cerniglia, Earl Avramis, Jennifer Tsoi, David Foulad, Thomas G Graeber, Begonya Comin-Anduix, Ahmed Samatar, Roger S Lo, Antoni Ribas

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Korea, Republic of 1 1%
Austria 1 1%
Unknown 81 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 31%
Researcher 22 26%
Student > Bachelor 10 12%
Other 7 8%
Student > Master 5 6%
Other 6 7%
Unknown 8 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 26%
Biochemistry, Genetics and Molecular Biology 21 25%
Medicine and Dentistry 15 18%
Immunology and Microbiology 4 5%
Chemistry 3 4%
Other 8 10%
Unknown 11 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.
All research outputs
#5,629,250
of 26,017,215 outputs
Outputs from Molecular Cancer
#475
of 1,962 outputs
Outputs of similar age
#53,154
of 250,649 outputs
Outputs of similar age from Molecular Cancer
#6
of 53 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,962 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,649 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.